Atai stock forecast.

About the ATAI Life Sciences N.V. stock forecast. As of 2023 November 11, Saturday current price of ATAI stock is 1.160$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. ATAI Life Sciences N.V. stock price has been showing a declining tendency so we believe that similar market segments …Nov 24, 2023 · On Friday 11/24/2023 the closing price of the ATAI Life Sciences N.V. Registered Shs share was $1.10 on NAS. Compared to the opening price on Friday 11/24/2023 on NAS of $1.12, this is a drop of 1 ... Get ATA IMS Bhd (ATAI.KL) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.The highest rated platform for investors in the world! TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. TipRanks stock market research and analysis, lets you see the track record and measured performance of any analyst or blogger, so you know who to trust!When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.

4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the …Web

Find the latest CXApp Inc. (CXAI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...

The company's stock is trading at about 20 cents per share as of Oct. 24. Cybin Inc . ( CYBN) Cybin, a Canadian psychedelic drug developer that produces treatments for depression, anxiety and ...Ad. LendingTree. As we look ahead to 2024, some of the most promising AI-powered stock-picking platforms use natural language processing to generate actionable predictions. For example, EquBot ...Exela Technologies Inc () Stock Market info Recommendations: Buy or sell Exela Technologies stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Exela Technologies share forecasts, stock quote and buy / sell signals below.According to present data Exela Technologies's XELA shares and potentially its …Historical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ...Find the latest Global Partners LP (GLP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

ATAI Life Sciences NV. $1.12. ATAI 7.69% ; Enveric Biosciences Inc. $1.68. ENVB 13.51% ; Compass Pathways PLC. $6.10. CMPS 2.01% ; ehave Inc. $0.0017. EHVVF 0.00%.

NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more.

Description. بايثون هي واحده من اكثر لغات البرمجه انتشارا في العالم واسهلهم واقواهم. اللعه مستخدمه تقريبا في اغلب التطبيقات اللي بنستخدمها في حياتنا اليوميه زي Youtube , Google Search , Instagram , Quora , Pinterest ...According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.3. 4. 2023. ... As atai currently has a stock price of $1.83 and a market cap of $304 million. Meaning it is trading at a 14% discount. And again, that ...43.55. -2.16%. 5.29M. Find the latest ATAI Life Sciences BV (ATAI) stock forecast, 12-month price target, predictions and analyst recommendations.WebATAI Life Sciences NV (ATAI) stock is trading at $2.17 as of 1:48 PM on Monday, Jul 17, a gain of $0.15, or 7.55% from the previous closing price of $2.02. The stock has traded between $2.00 and $2.20 so far today. Volume today is less active than usual.

Stock Price Forecast The 5 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 11.00, with a high estimate of 21.00 and a low …Web45. Based on our forecast, the price of ATAI will decline by -9.01% over the next 2 weeks and hit $0.95 by Thursday, December 14, 2023. In that time frame, ATAI 's share price is …WebNov 29, 2023 · Atai Life Sciences Stock Price, News & Analysis (NASDAQ:ATAI) $1.10 +0.01 (+0.92%) (As of 11/24/2023 ET) Compare Today's Range $1.08 $1.12 50-Day Range $1.06 $1.52 52-Week Range $1.05 $3.65 Volume 272,978 shs Average Volume 997,775 shs Market Capitalization $182.61 million P/E Ratio N/A Dividend Yield N/A Price Target $12.80 Atai Life Sciences N.V. Market Cap: 184.27M, Enterprise value: 101.26M, P/E: -1.93, PEG ratio: -0.17, EPS: -0.42, Revenue: 334K, EBITDA: -129.47M, ...Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ...Atai stock closed up 30% at 19.45 on the stock market today, paring gains after surging more than 50% earlier. ... Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views;

Atari S.A. is an interactive entertainment company and an iconic gaming industry brand that transcends generations and audiences. The company is globally recognized for its multi-platform, interactive entertainment and licensed products.

Jul 28, 2022 · Atai Life Sciences. One of Atai Life Sciences' early investors was venture capitalist Peter Thiel. The company went public in June 2021 at $15 and is currently trading at $3.78 with a market cap ... atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of ...The current price was close to the IPO price in September 2020. The $21.81 stock price right now is eight percent lower than the original $23.4 price. There is still hope for recovery if the price does not plunge toward zero. The technical outlook of this stock is pretty much the same as that of Atai. Mind Medicine (MNMD)Atai Life Sciences N.V. (ATAI) Stock Price, Quote & News - Stock Analysis 1.12 -0.02 (-2.19%) Nov 29, 2023, 10:07 AM EST - Market Overview Financials Statistics …WebMarket Cap. $464.54M. Enterprise Value -$9.65M. Total Cash (Recent Filing) $474.19M. Total Debt (Recent Filing) $0.00. Price to Earnings (P/E) -3.5. Beta 1.92. Next Earnings. Mar 26, 2024.The Plug Power stock price fell by -2.38% on the last day (Wednesday, 22nd Nov 2023) from $3.57 to $3.48. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 5.97% from a day low at $3.44 to a day high of $3.64. The price has fallen in 8 of the last 10 days and is down by -42.19% for this period.Nov 24, 2023 · On Friday 11/24/2023 the closing price of the ATAI Life Sciences N.V. Registered Shs share was $1.10 on NAS. Compared to the opening price on Friday 11/24/2023 on NAS of $1.12, this is a drop of 1 ... According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.13.80 0.00 0.00% The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —. Analyst rating Based on 7 analysts giving stock …WebAccording to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst …

Mind Medicine (MNMD) is a biotech company that develops psychedelic-inspired therapies for mental health disorders. Find out how analysts rate the stock and what are its growth prospects on TipRanks.com. You can also access the latest earnings reports, forecasts, and price movements of MNMD on the same platform.---Don't miss this opportunity to …

The ATA Inc. stock price gained 7.69% on the last trading day (Friday, 1st Dec 2023), rising from $1.04 to $1.12. During the last trading day the stock fluctuated 12.20% from a day low at $1.03 to a day high of $1.15. The price has risen in 5 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -2 million ...

How have NBSE shares performed in 2023? NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here.ATAI Life Sciences NV. $1.12. ATAI 7.69% ; Enveric Biosciences Inc. $1.68. ENVB 13.51% ; Compass Pathways PLC. $6.10. CMPS 2.01% ; ehave Inc. $0.0017. EHVVF 0.00%.3:24 pm. Articles. atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study …WebMeanwhile, Atai listed on the Nasdaq in June, raising $225 million at a valuation of $2.3 billion. The stock immediately popped 40% but it has since halved in value and Atai's current market cap ...Meanwhile, Atai listed on the Nasdaq in June, raising $225 million at a valuation of $2.3 billion. The stock immediately popped 40% but it has since halved in value and Atai's current market cap ...1.04%. $183.15M. AMAM | Complete Ambrx Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Historical daily share price chart and data for Atai Life Sciences since 2008 adjusted for splits and dividends. The latest closing stock price for Atai ...On Friday 11/24/2023 the closing price of the ATAI Life Sciences N.V. Registered Shs share was $1.10 on NAS. Compared to the opening price on Friday 11/24/2023 on NAS of $1.12, this is a drop of 1 ...

Find the latest Jet.AI Inc. (JTAI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Nov 29, 2023 · Analyst Forecast. According to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,110.76% from the latest price. Instagram:https://instagram. list of healthcare reitslelonbest financial audiobooksstock vinfast Atai's stock is hurting, but its pipeline is still packed with promising programs. With its shares down by 60% in the last 12 months and a recent layoff …WebAtai's stock is hurting, but its pipeline is still packed with promising programs. With its shares down by 60% in the last 12 months and a recent layoff …Web royal dutch stockhemmings car auctions Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock.Find the latest Sorrento Therapeutics, Inc. (SRNEQ) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ... magnifi ai reviews CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.